NEW YORK, August 25, 2026, 15:00 EDT — Shares of TNL Mediagene climbed 53% after Nasdaq granted an extension, preserving a 65% gap between the bid price and required threshold.
- TNL Mediagene stock climbed 52.7% to $0.6076 at 14:58 EDT as Nasdaq approved conditional continued listing.
- The stock must rise by 64.6% to meet Nasdaq’s $1 minimum bid requirement.
- Trading volume totaled 191.0 million shares, and traditional analyst coverage continued to be unavailable for verification.
Shares of TNL Mediagene NASDAQ:TNMG surged 52.7% on Tuesday after the digital media company secured a conditional extension from Nasdaq, allowing it to remain listed. The decision averted imminent delisting, though compliance issues persist.
At 14:58 EDT, the stock was changing hands at $0.6076, higher than Monday’s closing price of $0.3978. During the session, it moved between $0.5116 and $0.7990. Trading volume stood at 191.0 million shares.
The price gap is the relevant metric. At that moment, TNMG was trading 39.2% under Nasdaq’s $1 minimum bid. Climbing to $1 would need a further 64.6% gain, based on the calculation: $1 divided by $0.6076, minus one.
| Nasdaq condition | Required level | Deadline | Verified starting point |
|---|---|---|---|
| Minimum required bid price | $1.00 | September 21, 2026 | $0.6076 as of 14:58 EDT |
| Shareholders’ equity | $2.5 million | October 30, 2026 | $918,088 recorded December 31, 2025 |
Nasdaq’s hearings panel scheduled September 21 as the deadline for meeting the bid-price requirement. The panel also granted TNL Mediagene until October 30 to comply with the stockholders’ equity regulation. The company stated that falling short on either requirement would lead to delisting.
The equity requirement is distinct from market capitalization. TNL Mediagene’s reported stockholders’ equity for 2025 stood at $918,088, while the Nasdaq threshold is set at $2.5 million. This resulted in a declared deficit of approximately $1.58 million, prior to any subsequent adjustments in the balance sheet.
By 14:58 EDT, investors had traded about 75 times the firm’s 2.56 million shares outstanding. This volume may reflect multiple purchases and sales of the same shares. However, it highlights the speculative nature of the market response.
The company continues to be significantly larger than its listed equity valuation. TNL Mediagene posted $45.0 million in revenue for 2025. Digital Studio accounted for $18.7 million, representing 41.4%. The net loss for the year shrank to $44.6 million.
The company was valued at approximately $1.55 million at $0.6076 per share, representing just 3.4% of its forecast 2025 revenue. The modest ratio signals both financial and listing risks, beyond merely a discounted sales valuation.
| Verified analyst recommendations | Rating | Price target | Status on August 25, 2026 |
|---|---|---|---|
| Conventional sell-side analysis | Not reported | Not reported | No confirmed analyst number, consensus or target |
As a result, investors do not have a traditional research benchmark. According to StockAnalysis, which utilizes S&P Global Market Intelligence data, there is no available analyst coverage, consensus recommendation, or target price.
TNL Mediagene previously encountered the bid rule. Nasdaq notified the company that it was back in compliance in January following a one-for-20 reverse stock split in December 2025. The new panel ruling provides management a further limited opportunity.
Risks: A stock with a small float may see fast reversals after intraday gains. Raising funds may help with equity compliance but would dilute existing shareholders. Failure to meet either deadline would bring back the risk of delisting.
The next quantifiable hurdle appears ahead of the October equity deadline. TNMG has until September 21 to meet the necessary bid-price standard, giving the company fewer than four weeks from Tuesday’s disclosure.
Related articles: Stock Market
